Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: Relationships to harm avoidance and drive for thinness

Neuropsychopharmacology

Volumn 29, Issue 6, 2004, Pages 1143-1155

  Bailer, Ursula F ^a,b   Price, Julie C ^c   Meltzer, Carolyn C ^a,c   Mathis, Chester A ^c   Frank, Guido K ^a   Weissfeld, Lisa ^d   McConaha, Claire W ^a   Henry, Shannan E ^a   Brooks Achenbach, Sarah ^a   Barbarich, Nicole C ^a   Kaye, Walter H ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anorexia nervosa; Bulimia nervosa; Cingulate cortex; Positron emission tomography; Receptor; Serotonin

Indexed keywords

ALTANSERIN; FLUORINE 18; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ADULT; ANOREXIA NERVOSA; APPETITE; ARTICLE; BEHAVIOR; BODY WEIGHT; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALNUTRITION; MENSTRUAL CYCLE; NEUROTRANSMISSION; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; STATISTICAL SIGNIFICANCE; TEMPORAL LOBE;

ADULT; AGE FACTORS; ANOREXIA NERVOSA; BRAIN; BRAIN MAPPING; BULIMIA; DRIVE; FEMALE; FLUORINE RADIOISOTOPES; HARM REDUCTION; HUMANS; KETANSERIN; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT2A; THINNESS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2442713754     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300430     Document Type: Article

References (133)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington DC.
2. Arango V, Underwood MD, Mann JJ (1997). Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann NY Acad Sci 836: 269-287.
3. Artmann H, Grau H, Adelmann M, Schleiffer R (1985). Reversible and non-reversible enlargement of cerebrospinal fluid spaces in anorexia nervosa. Neuroradiology 27: 304-312.
4. 18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biol Psychiatry 45: 180-186.
5. Audenaert K, Van Laere K, Dumont F, Vervaet M, Goethals I, Slegers G et al (2003). Decreased 5-HT2a receptor binding in patients with anorexia nervosa. J Nucl Med 44: 163-169.
6. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS (1992). The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry 53: 17-28.
7. Beck AT, Ward M, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63.
8. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
9. Biver F, Wilder D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J (1997). Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 171: 444-448.
10. Blundell JE (1984). Serotonin and appetite. Neuropharmacology 23: 1537-1551.
11. Bonhomme N, Esposito E (1998). Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 18: 447-454.
12. Brewerton TD, Jimerson DC (1996). Studies of serotonin function in anorexia nervosa. Psychiatry Res 62: 31-42.
13. Buchsbaum MS, Wu JC, Siegel BV, Hackett E, Trenary M, Abel L et al (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41: 15-22.
14. Bulik CM, Sullivan PF, Fear JL, Joyce PR (1997). Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr Scand 96: 101-107.
15. Bulik CM, Sullivan PF, Kendler KS (1998). Heritability of binge-eating and broadly defined bulimia nervosa. Biol Psychiatry 44: 1210-1218.
16. 3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30: 565-574.
17. Casper RC (1990). Personality features of women with good outcome from restricting anorexia nervosa. Psychosom Med 52: 156-170.
18. Cheetham SC, Crompton MR, Katona CL, Horton RW (1988). Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443: 272-280.
19. Chowdhury U, Gordon I, Lask B (2001). Neuroimaging and anorexia nervosa. J Am Acad Child Adol Psychiatry 40: 738.
20. Chowdhury U, Gordon I, Lask B, Watkins B, Watt H, Christie D (2003). Early-onset anorexia nervosa: is there evidence of limbic system imbalance? Int J Eating Disord 33: 388-396.
21. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44: 573-588.
22. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD (1994). The Temperament and Character Inventory (TCI): A Guide to its Development and Use. Center for Psychobiology of Personality, Washington University: St Louis, MO.
23. Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Sieve LJ (1997). Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res 73: 1-14.
24. Critchley M (1953). The Parietal Lobes. Hafner: London.
25. Cyr M, Bosse R, Di Paolo T (1998). Gonadal hormones modulate 5-HT2A receptors: emphasis on the rat frontal cortex. Neuroscience 83: 829-836.
26. De Vry J, Schreiber R (2000). Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 24: 341-353.
27. de Zwaan M, Aslam Z, Mitchell JE (2002). Research on energy expenditure in individuals with eating disorders: a review. Int J Eat Disord 32: 127-134.
28. Deep AL, Nagy LM, Weltzin TE, Rao R, Kaye WH (1995). Premorbid onset of psychopathology in long-term recovered anorexia nervosa. Int J Eat Disord 17: 291-297.
29. Delvenne V, Lotstra F, Goldman S, Biver F, De M, V, Appelboom-Fondu J et al (1995). Brain hypometabolism of glucose in anorexia nervosa: a PET scan study. Biol Psychiatry 37: 161-169.
30. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12: 527-544.
31. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al (1999). PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-1387.
32. Drevets W, Price JL, Simpson RD, Reich T, Vannier M, Raichle ME (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
33. Eison AS, Mullins UL (1996). Regulation of central 5-HT2A receptors: a review of in vivo studies. Behav Brain Res 73: 177-181.
34. Ellison AR, Fong J (1998). Neuroimaging in eating disorders, In: Hoek HW, Treasure JL, Katzman MA (eds). Neurobiology in the Treatment of Eating Disorders. John Wiley & Sons Ltd: Chichester. pp 255-269.
35. Fichter MM, Herpertz S, Quadflieg N, Herpertz-Dahlmann B (1998). Structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10: updated (third) revision. Int J Eat Disord 24: 227-249.
36. Fichter MM, Pirke KM, Pollinger J, Wolfram GM, Brunner E (1990). Disturbances in the hypothalamo-pituitary-adrenal and other neuroendocrine axes in bulimia. Biol Psychiatry 27: 1021-1037.
37. First MB, Gibbon M, Spitzer RL, Williams JBW (1996). Users Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders - research version, (SCID-I, version 2.0, February 1996 FINAL VERSION), Biometrics Research Department, New York State Psychiatric Institute: New York.
38. Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C et al (2002). Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol Psychiatry 52: 896-906.
39. Freedman LJ, Insel TR, Smith Y (2000). Subcortical projections of area 25 (subgenual cortex) of the macaque monkey. J Compar Neurol 421: 172-188.
40. Frost RO, Marten P, Lahart C, Rosenblate R (1990). The dimensions of perfectionism. Cogn Ther Res 14: 449-468.
41. Garner DM (1991). Eating Disorder Inventory-2 Professional Manual. Psychological Assessment Resources, Inc.: Odessa, Florida.
42. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM (1995). Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152: 341-351.
43. Golden NH, Ashtari M, Kohn MR, Patel M, Jacobson MS, Fletcher A et al (1996). Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J Pediatr 128: 296-301.
44. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR et al (1989b). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46: 1012-1016.
45. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989a). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 1006-1011.
46. Gordon CM, Dougherty DD, Fischman AJ, Emans SJ, Grace E, Lamm R et al (2001). Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. J Pediatr 139: 51-57.
47. Gordon I, Lask B, Bryant-Waugh R, Christie D, Timimi S (1997). Childhood-onset anorexia nervosa: towards identifying a biological substrate. Int J Eat Disord 22: 159-165.
48. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res 507: 208-215.
49. Hamsher KS, Halmi KA, Benton AL (1981). Prediction of outcome in anorexia nervosa from neuropsychological status. Psychiatry Res 4: 79-88.
50. Herzog DB, Field AE, Keller MB, West JC, Robbins WM, Staley J et al (1996). Subtyping eating disorders: is it justified? J Am Acad Child Adolesc Psychiatry 35: 928-936.
51. Higley JD, Linnoila M (1997). Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann NY Acad Sci 836: 39-56.
52. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA et al (1999). Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156: 1091-1093.
53. Horne RL, Van Vactor JC, Emerson S (1991). Disturbed body image in patients with eating disorders. Am J Psychiatry 148: 211.
54. Katzman DK, Lambe EK, Mikulis DJ, Ridgley JN, Goldbloom DS, Zipursky RB (1996). Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr 129: 794-803.
55. Katzman DK, Zipursky RB, Lambe EK, Mikulis DJ (1997). A longitudinal magnetic resonance imaging study of brain changes in adolescents with anorexia nervosa. Arch Pediatr Adolesc Med 151: 793-797.
56. Kaye WH (1997). Anorexia and bulimia nervosa, obsessional behavior, and serotonin. In: Kaye WH, Jimerson DC (eds). Eating Disorders. Balliere's Tindell, Inc.: London.
57. Kaye WH, Frank GK, Meltzer CC, Price JC, McConaha CW, Crossan PJ et al (2001b). Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatry 158: 1152-1155.
58. Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR et al (1998). Alterations in serotonin activity and psychiatric symptomatology after recovery from bulimia nervosa. Arch Gen Psychiatry 55: 927-935.
59. Kaye WH, Gwirtsman HE, George DT, Ebert MH (1991). Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 48: 556-562.
60. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH (1988). CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 23: 102-105.
61. Kaye WH, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C et al (2001a). Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry 49: 644-652.
62. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ (1995). The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52: 374-383.
63. Kinsbourne M, Bemporad B (1984). Lateralization of Emotion: A Model and the Evidence. Lawrence Erlbaum: Hillsdale, NJ.
64. Klump KL, Bulik CM, Pollice C, Halmi KA, Fichter MM, Berrettini WH et al (2000). Temperament and character in women with anorexia nervosa. J Nerv Ment Dis 188: 559-567.
65. Klump KL, Miller KB, Keel PK, McGue M, Iacono WG (2001). Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol Med 31: 737-740.
66. Krieg JC, Pirke KM, Lauer C, Backmund H (1988). Endocrine, metabolic, and cranial computed tomographic findings in AN. Biol Psychiatry 23: 377-387.
67. Kuruoǧlu AC, Kapucu O, Atasever T, Arikan Z, Isik E, Ünlü M (1998). Technetium-99m-HMPAO brain SPECT in anorexia nervosa. J Nucl Med 39: 304-306.
68. Lambe EK, Katzman DK, Mikulis DJ, Kennedy SH, Zipursky RB (1997). Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry 54: 537-542.
69. Lammertsma AA (2002). Radioligand studies: imaging and quantitative analysis. Eur Neuropsychopharmacol 12: 513-516.
70. Leibowitz SF, Shor-Posner G (1986). Brain serotonin and eating behavior. Appetite 7: 1-14.
71. Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L (1991). Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 32: 2266-2272.
72. Lilenfeld LR, Kaye WH, Greeno CG, Merikangas KR, Plotnicov K, Pollice C et al (1998). A controlled family study of anorexia nervosa and bulimia nervosa: psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch Gen Psychiatry 55: 603-610.
73. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ et al (1990). Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10: 740-747.
74. 18F]altanserin: implications for kinetic modeling. In: Carson R, Daube-Witherspoon M, Herscovitch P (eds). Quantitative Brain Imaging with Positron Emission Tomography. Academic Press: San Diego. pp 293-298.
75. Lucki I (1998). The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44: 151-162.
76. Mann JJ (1999). Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21: 99S-105S.
77. Marcusson JO, Morgan DG, Winblad B, Finch CE (1984). Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res 311: 51-56.
78. Mathias JL, Kent PS (1998). Neuropsychological consequences of extreme weight loss and dietary restriction in patients with anorexia nervosa. J Clin Exp Neuropsychol 20: 548-564.
79. Mayberg HH, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression; serial changes and relationship to clinical response. Biol Psychiatry 48: 830-843.
80. Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S et al (2002). The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728-737.
81. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM (1994). The Yale-Brown-Cornell Eating Disorder Scale: development, use, reliability and validity. J Psychiatric Res 28: 425-445.
82. Meltzer CC, Kinaham P, Nichols TE, Greer PJ, Comtat C, Cantwell MN et al (1999). Comparative evaluation of MR-based partial volume correction schemes for PET. J Nucl Med 40: 2053-2065.
83. 18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 813: 167-171.
84. Meltzer CC, Zubieta JK, Links JM, Brakeman P, Stumpf MJ, Frost JJ (1996). MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab 16: 650-657.
85. 2A receptor binding is reduced in drug-naïve and unchanged in SSRI-responder depressed patients compared to healthy controls. Psychopharmacology 167: 72-78.
86. Mesulam MM (1999). Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events. Philos Trans R Soc London B 354: 1325-1346.
87. Metropolitan (1959). Metropolitan Life Insurance Company. New weight standards for men and women. Stat Bull Metrop Insur Co, pp 1-11.
88. Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, Da Silva J et al (2001). The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry 158: 78-85.
89. Minoshima S, Berger KL, Lee KS, Mintun MA (1992). An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med 33: 1579-1585.
90. 2A receptor binding and person-ality traits in healthy subjects: a positron emission tomography study. NeuroImage 17: 1470-1478.
91. Moses EL, Drevets WC, Smith G, Mathis CA, Kalro BN et al (2000). Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48: 854-860.
92. New AS, Trestman RL, Mitropoulou V, Benishay DS, Coccaro EF, Silverman J et al (1997). Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res 3: 17-26.
93. Nozoe S, Naruo T, Yonekura R, Nakabeppu Y, Soejima Y, Nagai N et al (1995). Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull 36: 251-255.
94. O'Dwyer AM, Lucey JV, Russell GF (1996). Serotonin activity in anorexia nervosa after long-term weight restoration: response to D-fenfluramine challenge. Psychol Med 26: 353-359.
95. Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW et al (2000). Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry 48: 1020-1023.
96. Palazidou E, Robinson PS, Lishman WA (1990). Neuroradiological and neuropsychological assessment in anorexia nervosa. Psychol Med 20: 521-527.
97. Pazos A, Probst A, Palacios JM (1987). Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21: 123-139.
98. 18F]altanserin bolus injection PET data I: consideration of radiolabeled metabolites in baboons. Synapse 41: 1-10.
99. Price JC, Lopresti BJ, Meltzer CC, Smith GS, Mason NS, Huang Y et al (2001b). Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans. Synapse 41: 11-21.
100. 11C]flumazenil. J Cereb Blood Flow Metab 13: 656-667.
101. Rastam M, Bjure J, Vestergren E, Uvebrant P, Gillberg IC, Wentz E et al (2001). Regional cerebral blood flow in weight-restored anorexia nervosa: a preliminary study. Dev Med Child Neurol 43: 239-242.
102. Rioux A, Fabre V, Lesch KP, Moessner R, Murphy DL, Lanfumey L et al (1999). Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci Lett 262: 113-116.
103. Saucier C, Morris SJ, Albert PR (1998). Endogenous serotonin-2A and -2C receptors in Balb/c-3T3 cells revealed in serotonin-free medium: desensitization and down-regulation by serotonin. Biochem Pharmacol 56: 1347-1357.
104. Saudou F, Hen R (1994). 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem Int 25: 503-532.
105. Shin JC, Young H (1978). The alteration of serotonin binding sites in aged human brain. Life Sci 23: 1441-1448.
106. Siever L, Trestman RL (1993). The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol 8: 33-39.
107. Simansky KJ (1996). Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73: 37-42.
108. Skaf CR, Yamada A, Garrido GEJ, Buchpiguel CA, Akamine S, Castro CC et al (2002). Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. J Affect Disord 68: 295-305.
109. Soubrie P (1986). Reconciling the role of central serotonin neuroses in human and animal behavior. Behav Brain Sci 9: 319-363.
110. Spielberger CD, Gorsuch RL, Lushene RE (1970). STAI Manual for the State Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA.
111. Spoont MR (1992). Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 112: 330-350.
112. Srinivasagam NM, Kaye WH, Plotnicov KH, Greeno C, Weltzin TE, Rao R (1995). Persistent perfectionism, symmetry, and exactness after long-term recovery from anorexia nervosa. Am J Psychiatry 152: 1630-1634.
113. Steiger H, Gauvin L, Israel M, Koerner N, Ng Ying Kin NM, Paris J et al (2001a). Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa. Arch Gen Psychiatry 58: 837-843.
114. Steiger H, Koerner N, Engelberg MJ, Israel M, Ng Ying Kin NM, Young SN (2001b). Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Res 103: 15-26.
115. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P et al (2001c). Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31: 85-95.
116. Stockmeier CA (1997). Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 836: 220-232.
117. Strober M (1980). Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J Psychosom Res 24: 353-359.
118. Strober M, Freeman R, Lampert C, Diamond J, Kaye W (2000). Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes. Am J Psychiatry 157: 393-401.
119. Summer BE, Fink G (1995), Estrogen increases the density of 5-HT2A receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol 54: 15-20.
120. Sunday SR, Halmi KA, Einhorn A (1995). The Yale-Brown-Cornell Eating Disorder Scale: a new scale to assess eating disorder symptomatology. Int J Eat Disord 18: 237-245.
121. Swayze II VW, Anderson A, Arndt S, Rajarethinam R, Sat Y, Andreasen NC (1996). Reversibility of brain tissue loss in anorexia nervosa assessed with a computerized Talairach 3-D proportional grid. Psychol Med 26: 381-390.
122. Swayze II VW, Andersen AE, Andreasen NC, Arndt S, Sato Y, Ziebell S (2003). Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord 33: 33-44.
123. Szmukler GI, Andrewes D, Kingston K, Chen L, Stargatt R, Stanley R (1992). Neuropsychological impairment in anorexia nervosa: before and after refeeding. J Clin Exp Neuropsychol 14: 347-352.
124. Takano A, Shiga T, Kitagawa N, Koyama T, Katoh C, Tsukamoto E et al (2001). Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT. Psychiat Res: Neuroimaging 107: 45-50.
125. 2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord 74: 149-158.
126. Wagner A, Ruf M, Braus DF, Schmidt MH (2003). Neuronal activity changes and body image distortion in anorexia nervosa. NeuroReport 14: 2193-2197.
127. Walsh BT, Devlin MJ (1998). Eating disorders: progress and problems. Science 280: 1387-1390.
128. Ward A, Brown N, Lightman S, Campbell IC, Treasure J (1998). Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa. Br J Psychiat 172: 351-358.
129. Watson CC, Newport D, Casey ME (1995). A single scatter simulation technique for scatter correction in 3D PET. Proceedings of the 1995 International Meeting on Fully Three-Dimensional Image Reconstruction in Radiology and Nuclear Medicine 215-219.
130. Wolfe BE, Metzger ED, Jimerson DC (1997). Research update on serotonin function in bulimia nervosa and anorexia nervosa. Psychopharmacol Bull 33: 345-354.
131. Woods RP, Cherry SR, Mazziotta JC (1992). Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 16: 620-633.
132. Woods RP, Mazziotta JC, Cherry SR (1993). MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536-546.
133. 2 receptors in major depression. Arch Gen Psychiatry 57: 850-858.